Titlebook: Lebensqualit?t im Alter; Therapie und Prophyl Rudolf Likar,Günther Bernatzky,Anton Sadjak Book 2017Latest edition Springer-Verlag GmbH Deut

孵化

書(shū)目名稱Lebensqualit?t im Alter影響因子(影響力)




書(shū)目名稱Lebensqualit?t im Alter影響因子(影響力)學(xué)科排名




書(shū)目名稱Lebensqualit?t im Alter網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Lebensqualit?t im Alter網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Lebensqualit?t im Alter被引頻次




書(shū)目名稱Lebensqualit?t im Alter被引頻次學(xué)科排名




書(shū)目名稱Lebensqualit?t im Alter年度引用




書(shū)目名稱Lebensqualit?t im Alter年度引用學(xué)科排名




書(shū)目名稱Lebensqualit?t im Alter讀者反饋




書(shū)目名稱Lebensqualit?t im Alter讀者反饋學(xué)科排名

Abominate

Longitude

nent current algorithms and methods for assessing the immunogenicity of the predicted peptides in vitro and in vivo. We also describe the complimentary approach of isolating major histocompatibility complexassociated peptides from target cells followed by sequencing using reverse phase highpressure

LATHE

Markus Schosserer,Johannes Grillarion. Several recently published studies have shown that HSV-elicited antitumor immune responses are an essential part of the overall antitumor effect produced by oncolytic HSVs, not only for controlling primary tumor growth, but also for preventing long distance metastases. In this chapter several ke

顯示

Alexander Hanikang graft-versus-host disease) from the bone marrow graft.. ALG also appeared to produce some benefit in patients with T-cell malignancies1. and there were anecdotal reports of benefit in multiple sclerosis, myasthenia gravis, systemic lupus erythematosus and other autoimmune disorders.

Stagger

Reinhold Popp things are changing. The nine chapters of this volume detail nine quite different approaches to manipulating the immune system for therapeutic benefit. All are experimental and they have been attended with greater or lesser degrees of success. In some cases their main effect has been to elucidate t

殘暴

根除

Claudia Petru,Margarete Sprinzulfate chain. The HN3 and HS20 antibodies inhibit Wnt/Yap signaling and suppress HCC cell growth. To improve anti-tumor efficacy, anti-GPC3 immunotoxins and CAR-T cell therapies have been developed. The Wnt-blocking HN3 immunotoxin is more potent than YP7 immunotoxin. With an engineered toxin, the H

委派

Peter Dovjakof T-cells and the various markers that help in identification of T-cells, differentiation of T-cells is described; different types of effector T-cells such as T.1 cells, T.2 cells, T.17 cells, Tregs and CTLs are discussed along with details of their origin, secretions, functions and role in tumor m

prodrome